Somewhat Positive Press Coverage Somewhat Unlikely to Affect Calgon Carbon (NYSE:CCC) Stock Price

Share on StockTwits

Media headlines about Calgon Carbon (NYSE:CCC) have trended somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Calgon Carbon earned a media sentiment score of 0.17 on Accern’s scale. Accern also gave headlines about the industrial products company an impact score of 45.8634643996535 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Separately, ValuEngine raised Calgon Carbon from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $20.83.

Shares of CCC stock opened at $21.50 on Monday. Calgon Carbon has a 52 week low of $12.00 and a 52 week high of $22.10. The company has a debt-to-equity ratio of 0.54, a current ratio of 2.57 and a quick ratio of 1.60.

Calgon Carbon Company Profile

Calgon Carbon Corporation is a manufacturer of activated carbon, with capabilities in ultraviolet (UV) light disinfection. The Company provides purification solutions for drinking water, wastewater, pollution abatement, and a range of industrial and commercial manufacturing processes. The Company operates through four segments: Activated Carbon and Service, Equipment, Consumer and Other.

Insider Buying and Selling by Quarter for Calgon Carbon (NYSE:CCC)

Receive News & Ratings for Calgon Carbon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calgon Carbon and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.